General population and cancer patient norms for the functional assessment of cancer therapy-general (FACT-G)
General population and cancer patient norms for the functional assessment of cancer therapy-general (FACT-G)
复制标题
DOI：
10.1177/0163278705275341
复制
发表时间：
2005-06-01
影响因子：
2.9
通讯作者：
Cella, D
中科院分区：
文献类型：
--
作者：
Brucker, PS;Yost, K;Cella, D
鉴于每年诊断的新癌症病例数量和生存率的增加，拥有临床有用的健康相关生活质量（HRQOL）工具的重要性已经增加。癌症治疗功能评估-一般（FACT-G）是一种已在全球范围内用于评估HRQOL的工具。此前，由于缺乏已发表的规范性数据，FACT-G的使用受到限制。规范性数据有助于消费者通过将他们的个人或个人群体的得分与参考群体进行比较，将他们的结果置于适当的背景下。在这里，我们提供了两个参考组的FACT-G的规范性数据：（a）一般美国成年人群的样本和（B）成人癌症患者的大型异质性样本。此外，我们还展示了规范数据的各种用途。
Given the number of new cancer cases diagnosed each year and the increases in survival rates, the importance of having a clinically useful health-related quality of life (HRQOL) instrument has increased. The Functional Assessment of Cancer Therapy-General (FACT-G) is one such instrument that has been used worldwide to assess HRQOL. Previously, the use of the FACT-G had been limited because of a lack of published normative data. Normative data are useful for consumers to place their results in an appropriate context by comparing their scores of individuals or group of individuals to a reference group. Here, we present normative data for the FACT-G for two reference groups: (a) a sample of the general U.S. adult population and (b) a large, heterogeneous sample of adult patients with cancer. In addition, we demonstrate various uses of the normative data.